Cardiac POCT - D-Dimer Immunoassay Test Kit
D-Dimer diagnostic test is a proprietary point-of-care fluorescence immunoassay designed for prompt and accurate in-vitro quantitative measurement.
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- Optical Q
- Payment Terms
- T/T
- Production method
- OBM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic devices, ivd, poct, fluorescence immunoassay
- Category
- Chemical Reagents & Products
Product name | Cardiac POCT - D-Dimer Immunoassay Test Kit | Certification | CE |
---|---|---|---|
Category | Chemical Reagents & Products | Material | - |
Keyword | diagnostic devices , ivd , poct , fluorescence immunoassay | Unit Size | - |
Brand name | Optical Q | Unit Weigh | - |
origin | South Korea | Stock | 100000 |
Supply type | OBM | HS code | 3822 |
Product Information
The Optical Q™ D-Dimer diagnostic test is a proprietary point-of-care (POCT) fluorescence immunoassay (FIA) designed for prompt and accurate in-vitro quantitative measurement of D-Dimer.
D-Dimer, containing two D fragments of the fibrin protein joined by a cross-link, is a fibrin degradation product (FDP), which is a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis.
The Optical Q™ D-Dimer reagent test is thus helping diagnose conditions that cause inappropriate blood clots such as deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and to monitor treatment of DIC and excessive clotting conditions.
Specifications
Working range | 50-10,000 ng/mL |
Reference range | <500 ng/mL |
CV | <10% |
Sample type | Plasma |
Sample volume | 100 µL |
Loading volume | 100 µL |
Assay time | 15 minutes |
Storage condition | Cartridge: 2-30 °C / Detection buffer: 2-8 °C |
Shelf life | 24 months |
Ordering Information
Cat No. | Description | Packing Size | Storage Condition |
OB141-25 | Optical Q D-Dimer | 25 Test/Box | Cartridge: 2-30℃ Detection Buffer: 2-8℃ |
- Product Info Attached File
- Verified Certificate
-
B2B Trade
Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | T/T | Shipping time | Negotiable |
- President
- Jeawon Kim, Minyoung Choi
- Address
- Bonbukwan-401, 76, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Korea
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2019
- Company introduction
-
OptiBio is a South Korean in-vitro diagnostics (IVD) company focused in researching, developing, and manufacturing cutting edge fluorescence immunoassay (FIA) solutions. In 2020, OptiBio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach to immunoassay.
OptiBio's competitive advantage stems from its strong foundation of experts, each specialized in fields crucial for product development. Our R&D is divided into 3 different teams of scientists and engineers dedicated to the independent development of diagnostic markers, test kits, and analyzers.
Our fundamental approach to in-house specialization allows OptiBio to constantly improve our product performance, customize our solutions based on client feedback, develop new test parameters, and respond to changing market needs.
OptiBio will continue to create, improve, and innovate world-class diagnostic solutions in the field of fluorescence immunoassay and point-of-care testing (POCT). Through this, we aim to ultimately transform medical diagnosis into a universally available right.
- Main Markets
-
Brazil
Ethiopia
Germany
Mexico
Nigeria
- Main Product
- Attached File